Publications

Publications 3051 - 3075 de 33557
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Anti-Thymocyte Globulins Induced Immunomodulatory Effect and Increased Regulatory T Cell in a In Vitro Model of Allogeneic Cell Coculture
M. Colladant; J. Lion; P. Saas; S. Perruche; D. Ducloux; N. Mooney; J. Bamoulid
2020
Anti-TNF treatment of reactive arthritis. A mono-centric experience
A. Brinster; X. Guillot; C. Prati; D. Wendling
2017
10.1016/j.jbspin.2016.02.022
Anti-tumor efficacy in SIOPEL 6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB).
P.Rachel Brock; R. Maibach; M. Childs; K. Rajput; E.A. Neuwelt; D. Roebuck; M.James Sullivan; V. Laithier; M. Ronghe; L. Lockwood; P. dall'Igna; E. Hiyama; B. Brichard; J. Skeen; M.Elena Mateos; M. Fabre; A.Atreiya Rangaswami; M. Capra; P. Czauderna; B. Morland
2015
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial
G. Meyer; B. Besse; H. Doubre; A. Charles-Nelson; S. Aquilanti; A. Izadifar; R. Azarian; I. Monnet; C. Lamour; R. Descourt; G. Oliviero; L. Taillade; C. Chouaid; F. Giraud; P.E. Falcoz; M.P. Revel; V. Westeel; A. Dixmier; J. Tredaniel; S. Dehette; C. Decroisette; A. Prevost; E. Pichon; E. Fabre; J.C. Soria; S. Friard; J.B. Stern; L. Jabot; G. Dennewald; G. Pavy; P. Petitpretz; J.M. Tourani; M. Alifano; G. Chatellier; P. Girard
2018
10.1183/13993003.01220-2018
Antiangiogenic and immunomodulatory effects of metronomic cyclophosphamide (CPM) treatment in prostate cancer patients with PSA failure
O. Adotevi; F. Calcagno; T. Maurina; S. Kim; A. Thiery-Vuillemin; C. Borg; Y. Godet; C. Laheurte
2014
10.1158/1538-7445.AM2014-2588
Antibacterial and Immunomodulatory Properties of Acellular Wharton's Jelly Matrix
M. Dubus; L. Scomazzon; J. Chevrier; C. Ledouble; A. Baldit; J. Braux; F. Gindraux; C. Boulagnon; S. Audonnet; M. Colin; H. Rammal; C. Mauprivez; H. Kerdjoudj
2022
10.3390/biomedicines10020227
Antibacterial properties and reduction of MRSA biofilm with a dressing combining polyabsorbent fibres and a silver matrix
N. Desroche; C. Dropet; P. Janod; J. Guzzo
2016
10.12968/jowc.2016.25.10.577
Antibacterial properties of glycosylated surfaces: variation of the glucosidal moiety and fatty acid conformation of grafted microbial glycolipids
C. Valotteau; S.L.K.V. Roelants; P. Dhasaiyan; S. Zibek; M. Guenther; W. Soetaert; B. Everaert; C.M. Pradier; F. Babonneau; N. Baccile; V. Humblot
2020
10.1039/d0me00059k
Antibiofilm effect of ultrasound combined with microbubbles against Staphylococcus epidermidis biofilm
Y. Dong; Y. Xu; P. Li; C. Wang; Y. Cao; J. Yu
2017
10.1016/j.ijmm.2017.06.001
Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study
L. Derosa; A.Costa Silva; C. Dalban; E. Colomba; S. Negrier; C.M. Chevreau; G. Gravis; S.M. Oudard; B. Laguerre; P. Barthelemy; D. Borchiellini; M. Gross-Goupil; L. Geoffrois; F. Rolland; A. Thiery-Vuillemin; F. Joly; S. Ladoire; F. Tantot; B. Escudier; L. Albiges
2021
10.1016/j.annonc.2021.08.053
Antibiotic prophylaxis and intravitreal injections: impact on the incidence of acute endophthalmitis
F. Baudin; E. Benzenine; A.S. Mariet; A.M. Bron; V. Daien; J.F. Korobelnik; C. Quantin; C. Creuzot-Garcher
2019
Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital
L. Molina; Z. Udaondo; E. Duque; M. Fernandez; C. Molina-Santiago; A. Roca; M. Porcel; J. de la Torre; A. Segura; P. Plesiat; K. Jeannot; J.L. Ramos
2014
10.1371/journal.pone.0081604
Antibiotic stewardship: A 2017 update
B. Castan; P. Lesprit; S. Alfandari; E. Bonnet; S. Diamantis; R. Gauzit; S. Kerneis; J. Leroy; X. Lescure; V. Meyssonnier; V. Mondain; P. Pavese; C. Rabaud; J.P. Stahl; P. Tattevin; F. Roblot; C. Pulcini; SPILF
2017
10.1016/j.medmal.2017.06.007
Antibiotic stewardship: What's new?
B. Castan; P. Lesprit; S. Alfandari; E. Bonnet; S. Diamantis; R. Gauzit; S. Kerneis; J. Leroy; F.X. Lescure; V. Mondain; P. Pavese; C. Rabaud; J.P. Stahl; P. Tattevin; F. Roblot; C. Pulcini
2016
10.1016/j.medmal.2016.11.001
Antibiotic susceptibility of E. coli isolated from pediatric urine microscopy and culture tests: A 6-year study
C. Feuillebois; B. Salles; G. Haore; R. Vieux; C. Chirouze
2020
10.1016/j.medmal.2019.08.004
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial
L. Bernard; A. Dinh; I. Ghout; D. Simo; V. Zeller; B. Issartel; V. Le Moing; N. Belmatoug; P. Lesprit; J.P. Bru; A. Therby; D. Bouhour; E. Denes; A. Debard; C. Chirouze; K. Fevre; M. Dupon; P. Aegerter; D. Mulleman; D. Treatment
2015
10.1016/S0140-6736(14)61233-2
Antibiotic Use Does Not Appear to Influence Response to Nivolumab
C. Kaderbhai; C. Richard; J.David Fumet; A. Aarnink; P. Foucher; B. Coudert; L. Favier; A. Lagrange; E. Limagne; R. Boidot; F. Ghiringhelli
2017
10.21873/anticanres.11680
Antibiotic's real life profile and safety: a regional study
M.B.Valnet Rabier; B. Slekovec; S. Sahli; A. Dautriche; S. Davani; A. Grandvuillemin
2017
Antibiotic's real life profile and safety: a regional study
M.B.Valnet Rabier; B. Slekovec; S. Sahli; A. Dautriche; S. Davani; A. Grandvuillemin
2017
Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis
M. Collard; Z. Lakkis; J. Loriau; D. Mege; C. Sabbagh; J.H. Lefevre; L. Maggiori
2020
10.1016/j.jviscsurg.2020.04.014
Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study
M. Coppry; C. Jeanne-Leroyer; P. Noize; C. Dumartin; A. Boyer; X. Bertrand; V. Dubois; A.M. Rogues
2019
10.1093/jac/dky427
Antibiotics usage in infants during the first 18 months of life in a cohort study in Benin: the role of mothers and children's characteristics at birth and infants' clinical findings at consultations
A. Brembilla; F. Mauny; A. Garcia; G.K. Koura; P. Deloron; J.F. Faucher
2015
Antibiotics usage in infants during the first 18 months of life in a cohort study in Benin: the role of mothers and children's characteristics at birth and infants' clinical findings at consultations
A. Brembilla; F. Mauny; A. Garcia; G.K. Koura; P. Deloron; J.F. Faucher
2015
Antibiotics usage in infants during the first 18 months of life in Benin: a population-based cohort study
A. Brembilla; F. Mauny; A. Garcia; K.G. Koura; P. Deloron; J.F. Faucher
2016
10.1007/s10096-016-2587-y
Antibiotrophy: Key Function for Antibiotic-Resistant Bacteria to Colonize Soils-Case of Sulfamethazine-Degrading Microbacterium sp. C448
L. Billet; S. Pesce; N. Rouard; A. Spor; L. Paris; M. Leremboure; A. Mounier; P. Besse-Hoggan; F. Martin-Laurent; M. Devers-Lamrani
2021
10.3389/fmicb.2021.643087

Pages